Company Korea Arlico Pharm Co.,Ltd.

A260660

KR7260660006

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sector Generic Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
4,885 ^KRW	-0.10%		-3.27%	-14.30%

2023	Korea Arlico Pharm Co.,Ltd. announced that it has received KRW 10 billion in funding	CI
2023	Korea Arlico Pharm Co.,Ltd. announced that it expects to receive KRW 10 billion in funding	CI

KOREA ARLICO PHARM CO.,LTD. is a Korea-based company that mainly engaged in the manufacturing and sale of pharmaceuticals. The Company manufactures and sells circulation system drugs, digestion drugs, anti-inflammatory analgesic, other prescription drug for treating hypertension, hyperlipidemia, peptic ulcer, indigestion, osteoarthritis, pain, and dementia, among others. The Company distributes its products within the domestic market and to overseas markets.

KRW in Million	2022	Weight	2023	Weight	Delta
Pharmaceutical 100.0 %	167,737	100.0 %	187,155	100.0 %	+11.58%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 100.0 %	167,737	100.0 %	187,155	100.0 %	+11.58%

Managers	Title	Age	Since
Hang-Gu Lee CEO	Chief Executive Officer	63	-
Chan-Sub Kim BRD	Director/Board Member	58	19-03-13
Yong-Hwa Lee AUD	Comptroller/Controller/Auditor	56	-

Members of the board	Title	Age	Since
Hang-Gu Lee CEO	Chief Executive Officer	63	-
Chan-Sub Kim BRD	Director/Board Member	58	19-03-13
Moon-Sung Lee BRD	Director/Board Member	57	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	15,327,021	8,862,074 ( 57.82 %)	313,630 ( 2.046 %)	57.82 %

Name	Equities	%	Valuation
Hang-Gu Lee 34.39 %	5,271,446	34.39 %	19 M ₩
Soon-ja Kim 2.173 %	333,075	2.173 %	1 M ₩
KOREA ARLICO PHARM CO.,LTD. 2.046 %	313,630	2.046 %	1 M ₩
Soon-young Kim 0.9987 %	153,075	0.9987 %	561 530 ₩
Ji-sook Lee 0.8991 %	137,812	0.8991 %	505 540 ₩
Ji-Hye Lee 0.8991 %	137,812	0.8991 %	505 540 ₩
Jin-bok Lee 0.8991 %	137,812	0.8991 %	505 540 ₩
Jung-eun Lee 0.8991 %	137,812	0.8991 %	505 540 ₩
Seo-joon Hwang 0.6958 %	106,643	0.6958 %	391 202 ₩
Jum-sook Yeo 0.3725 %	57,093	0.3725 %	209 436 ₩

Name	Equities	%	Valuation
KOREA ARLICO PHARM CO.,LTD. 2.05%	313,630	2.05%	1,150,498 $

Korea Arlico Pharm Co., Ltd.

Arlico Pharmaceutical Building 7-21 Baumeo-ro 27-gil

06752, Seoul

http://www.arlico.co.kr

address Korea Arlico Pharm Co.,Ltd.(A260660)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Generic Pharmaceuticals

	1st Jan change	Capi.
KOREA ARLICO PHARM CO.,LTD.	-14.30%	54.14M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+15.91%	41.97B
OTSUKA HOLDINGS CO., LTD.	+22.40%	22.34B
SANDOZ GROUP AG	+18.48%	15.25B
CIPLA LIMITED	+16.12%	14B
ZYDUS LIFESCIENCES LIMITED	+45.12%	12.06B
ONO PHARMACEUTICAL CO., LTD.	-9.58%	6.8B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.18%	5.49B

Generic Pharmaceuticals